跳至主要内容
临床试验/EUCTR2014-005197-11-IT
EUCTR2014-005197-11-IT进行中(未招募)1 期

Sugammadex and neurogical effects central - SENC

AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII0 个研究点目标入组 56 人开始时间: 2015年5月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Aged between 18 and 65 years old
  • Risk class ASA I-II
  • indication for tracheal intubation
  • surgery is indicated only general anesthesia
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 56
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Age below 18 years and 65 years
  • Acute or chronic renal insufficiency (serum creatinine = 1.5)
  • Hepatic impairment (PTINR, transaminases, LDH, bilirubin 1.5 times the normal value, PTL <70,000 mm3)
  • Emergency operations
  • Neurological disorders in treatment (including Parkinson's)
  • Known hypersensitivity to sugammadex or neostigmine or excipients contained therein
  • Subjects with asthma

研究者

发起方
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII

相似试验